Your browser doesn't support javascript.
loading
Targeting mGluR group III for the treatment of neurodegenerative diseases.
Rabeh, Nadia; Hajjar, Baraa; Maraka, Jude O; Sammanasunathan, Ashwin F; Khan, Mohammed; Alkhaaldi, Saif M I; Mansour, Samy; Almheiri, Rashed T; Hamdan, Hamdan; Abd-Elrahman, Khaled S.
Afiliación
  • Rabeh N; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates; Department of Anesthesiology, Pharmacology and Therapeutics, and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, Britis
  • Hajjar B; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Maraka JO; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Sammanasunathan AF; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Khan M; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Alkhaaldi SMI; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Mansour S; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Almheiri RT; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
  • Hamdan H; Department of Physiology and Immunology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates; Healthcare Engineering Innovation Center (HEIC), Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.
  • Abd-Elrahman KS; Department of Anesthesiology, Pharmacology and Therapeutics, and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada; Department of Pharmacology and Therapeutics, College of Medicine and Health Science, Khalifa University, Abu Dhabi
Biomed Pharmacother ; 168: 115733, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37862967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Glutamato Metabotrópico / Enfermedades Neurodegenerativas Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Glutamato Metabotrópico / Enfermedades Neurodegenerativas Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article